Sun Pharma announced that the USFDA has granted a tentative approval for an Abbreviated New Drug Application (ANDA) for generic Strattera®, atomoxetine hydrochloride capsules.
These atomoxetine hydrochloride capsules, therapeutically equivalent to Strattera® capsules from Eli Lilly, are available in seven strengths viz. 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg [...]
Content Partners
Direct Access: Business Wire India
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its application for Nicardipine Hydrochloride Injections.
These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD [...]
Sun Pharma announced that the USFDA has granted tentative approval to an Abbreviated New Drug Application (ANDA) for generic Gleevec®, imatinib mesylate tablets.
These imatinib mesylate tablets, therapeutically equivalent to Gleevec® tablets from Novartis, have two strengths viz. 100 mg and 400 mg and have annual sales of approximately USD 950 million in the [...]
New Delhi, October 07, 2009 – IOL Chemicals and Pharmaceuticals Limited (IOLCP), one of the largest producers of organic chemicals and bulk drugs in India, has announced that it has received DMF Registration No. 2009-179 from Health Canada, the drug regulatory body of Canada for exporting its most successful pharmaceutical product, the anti-inflammatory drug [...]
Biocon, India’s pioneering biotechnology enterprise, announced today that the company has been ranked as the 7th largest employer amongst the top global biotechnology companies, according to a report released by Med Ad News. The report takes into consideration drug based firms, as these companies provide the best numbers to track the progress of the sector. [...]
The Clinical Pharmacology Unit (CPU) of GVK Biosciences (GVK BIO) received approvals from all major regulatory bodies globally including USFDA, AFSAAPS, WHO and ANVISA. The approvals open global markets to GVK BIO’s clients in the US, Europe and Latin American countries in addition to the domestic sector.
Manni Kantipudi, President of GVK BIO stated, “The [...]
